You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
凱普生物(300639.SZ):全資子公司獲授予發明專利權通知書
格隆匯 06-05 16:24

格隆匯6月5日丨凱普生物(300639.SZ)公佈,公司的全資子公司廣州凱普醫藥科技有限公司(“凱普醫藥”)、廣州凱普醫學檢驗所有限公司(“廣州凱普檢驗所”)和廣州凱普生物科技有限公司(“廣州凱普”)於近日收到國家知識產權局下發的授予發明專利權通知書,發明創造名稱為一種重疊延伸PCR結合Sanger測序檢測不連續多DNA位點的方法。

該發明公開了一種重疊延伸PCR結合Sanger測序檢測不連續多DNA位點的方法,該方法一對用於重疊延伸PCR的全長擴增的引物。該發明通過一次PCR將不連續的位點連接成一條DNA片段,對這條包含多個檢測位點所在片段,可以一次性進行Sanger測序分析,利用該發明可以將任意的2~4個包含各自檢測位點的片段拼接連接形成融合片段,快速、簡單,不需要限制性內切酶,中間無任何非目的基因的DNA序列,進而檢測的檢測突破了Sanger測序讀長的限制,可以通過一個Sanger測序反應同時檢測多個不連續的DNA位點。該發明的取得不會對公司目前的經營狀況產生重大的影響,但有利於進一步完善公司的知識產權體系,充分發揮公司的知識產權優勢,促進公司產品結構的不斷豐富,提升公司的核心競爭力。

公司將嚴格依照辦理登記手續通知書的內容辦理登記手續,在按期辦理登記手續後,國家知識產權局將作出授予專利權的決定,頒發發明專利證書,並予以登記和公告,專利權自公告之日起生效,有效期自申請日起二十年。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account